Vanguard Group’s Procept Biorobotics PRCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $302M | Buy |
5,248,072
+120,935
| +2% | +$6.97M | ﹤0.01% | 1299 |
|
|
2025
Q1 | $299M | Sell |
5,127,137
-13,289
| -0.3% | -$774K | 0.01% | 1274 |
|
|
2024
Q4 | $414M | Buy |
5,140,426
+297,075
| +6% | +$23.9M | 0.01% | 1150 |
|
|
2024
Q3 | $388M | Buy |
4,843,351
+131,204
| +3% | +$10.5M | 0.01% | 1192 |
|
|
2024
Q2 | $288M | Buy |
4,712,147
+465,398
| +11% | +$28.4M | 0.01% | 1287 |
|
|
2024
Q1 | $210M | Buy |
4,246,749
+62,164
| +1% | +$3.07M | ﹤0.01% | 1488 |
|
|
2023
Q4 | $175M | Buy |
4,184,585
+109,694
| +3% | +$4.6M | ﹤0.01% | 1583 |
|
|
2023
Q3 | $134M | Buy |
4,074,891
+385,271
| +10% | +$12.6M | ﹤0.01% | 1648 |
|
|
2023
Q2 | $130M | Buy |
3,689,620
+420,850
| +13% | +$14.9M | ﹤0.01% | 1709 |
|
|
2023
Q1 | $92.8M | Buy |
3,268,770
+33,906
| +1% | +$963K | ﹤0.01% | 1866 |
|
|
2022
Q4 | $134M | Buy |
3,234,864
+396,340
| +14% | +$16.5M | ﹤0.01% | 1638 |
|
|
2022
Q3 | $118M | Buy |
2,838,524
+381,894
| +16% | +$15.8M | ﹤0.01% | 1683 |
|
|
2022
Q2 | $80.3M | Buy |
2,456,630
+1,848,617
| +304% | +$60.4M | ﹤0.01% | 1948 |
|
|
2022
Q1 | $21.3M | Buy |
608,013
+23,439
| +4% | +$820K | ﹤0.01% | 2739 |
|
|
2021
Q4 | $14.6M | Buy |
584,574
+128,780
| +28% | +$3.22M | ﹤0.01% | 3012 |
|
|
2021
Q3 | $17.4M | Buy |
+455,794
| New | +$17.4M | ﹤0.01% | 2940 |
|